Research Bridge Partners
Venture Capital and Private Equity Principals
Dallas, Texas 792 followers
World Class Returns with Midcontinent Roots
About us
Research Bridge Partners makes formative investments in biomedical startup companies based on the breakthroughs of preeminent innovators at mid-continent research universities—creating high quality investment opportunities that are sourced from geographies with thinner commercialization resources.
- Website
-
http://www.researchbridgepartners.org
External link for Research Bridge Partners
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- Dallas, Texas
- Type
- Nonprofit
- Founded
- 2016
Locations
-
Primary
Get directions
3000 Pegasus Park Dr
Dallas, Texas 75247, US
Employees at Research Bridge Partners
-
Matt Tremblay, Ph.D.
CEO Blackbird Laboratories
-
Sunil Singhal
William Maul Measey Professor and Chief of Thoracic Surgery at University of Pennsylvania Perelman School of Medicine
-
Maggie Colonnetta
Senior Associate at Research Bridge Partners | Molecular Biology PhD
-
Lauren Cozzens
Cancer Biology PhD Candidate | Univeristy of Colorado Anschutz Medical Campus | Intern, Research Bridge Partners
Updates
-
One of the most common questions posed to RBP: why venture philanthropy?
For nearly a decade, our approach has centered on venture philanthropy, bridging academic research with biotechnology. This method has proven to be cost-effective and adaptable compared to traditional capital. I propose investors, foundations, and educational institutions trial this balance sheet to explore the benefits of this financial model. More on why here: [Link to the full article: https://lnkd.in/eMvKQBXV]
-
Research Bridge Partners reposted this
Congratulations, Jibe Therapeutics and Austin Boesch, on winning the American Cancer Society Golden Ticket Pitch Competition. We look forward to welcoming you to Pegasus Park! Thank you, AbbVie, Research Bridge Partners, and BioLabs Pegasus Park - North Texas for your collaboration on this exciting initiative. #biotech #lifescience #innovation #pitchcompetition
-
Research Bridge Partners reposted this
📣 Attention all biotech enthusiasts! 📣 Join us for an incredible night of networking with the Dallas life science ecosystem over refreshments and appetizers brought to you by BrightEdge - American Cancer Society , AbbVie, Research Bridge Partners, BioLabs Pegasus Park - North Texas, and Lyda Hill Philanthropies! When: March 11, 2025 Time: 4:00 – 6:00 PM CST Where: First floor Pegasus Park Tower (3000 Pegasus Park Drive) You can RSVP for the free event here: https://lu.ma/gz09sft9. The winner of the 2025 ACS BrightEdge Golden Ticket will be announced at 4:30 PM! 🎉 #Innovation #Oncology #Startups #GoldenTicket #Dallas Ryan Margolis, PhD, Farnaz Bakhshi, Stephen Curtis, Jess Miciak, PhD, Christina Vorvis, PhD, Debra Chao, Theodora Ross, Andrew Souers, Alberto Zacarias, Susan Morgan-Lappe, Alex Shoemaker, Lydia McClure, Maggie Colonnetta Gabby Everett, Lili Clark, Matthew Crommett
-
Research Bridge Partners reposted this
Erisyon is delighted to announce that we've received $2.2M from the Cancer Prevention Research Institute of Texas to bring single molecule protein sequencing to the fight against cancer. If you'll be in SF during the JPM Healthcare Conference and would like to learn more about our work, as well as get a peek at our instruments, please don't hesitate to reach out! https://lnkd.in/efXNWsr9
-
Research Bridge Partners reposted this
📣 Calling all oncology-focused early-stage start-ups! BrightEdge is partnering with Lyda Hill Philanthropies, AbbVie, BioLabs Pegasus Park - North Texas, and Research Bridge Partners to offer an amazing opportunity for oncology-focused startups: a Golden Ticket! This exclusive award includes: ✨ One full year of lab space with unlimited equipment access ✨ $25,000 in non-dilutive funding ✨ Mentorship from the ACS BrightEdge, AbbVie, and Research Bridge Partners teams Don’t miss your chance to accelerate your impact in oncology innovation! Applications close January 17, 2025. Apply now: American Cancer Society BrightEdge 2024 Golden Ticket | BioLabs (https://lnkd.in/gevRV58n) #Innovation #Oncology #Startups #GoldenTicket #Dallas Farnaz B., Christina Vorvis, PhD, Debra Chao, Danjuma Q., Doug Faunce, PhD, Lydia McClure, Maggie Colonnetta, Gabby Everett, Matthew Crommett, Theodora Ross, Molly James-Lundak, Christian R. Schubert, Ryan Margolis, PhD
-
Research Bridge Partners reposted this
Exciting news! BioLabs Pegasus Park is partnering with BrightEdge - American Cancer Society , AbbVie, and Research Bridge Partners to offer an amazing opportunity for oncology-focused startups: a Golden Ticket! This exclusive award includes: ✨ One full year of lab space with unlimited equipment access ✨ $25,000 in non-dilutive funding ✨ Mentorship from the BrightEdge, AbbVie, and Research Bridge Partners teams Don’t miss your chance to accelerate your impact in oncology innovation! Applications close January 17, 2025. Apply now: https://lnkd.in/gevRV58n #Innovation #Oncology #Startups #GoldenTicket #Dallas
-
-
Research Bridge Partners reposted this
We are thrilled to announce that our Phase 1 Single-Ascending Dose Safety study and Phase IIa Influenza Challenge study have received full approval to proceed. More information will be available shortly via press release. Dosing will commence on November 19th!
-
Research Bridge Partners reposted this
The Erisyon team continues to chip away at the problem of single molecule protein sequencing…